| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A maintained absolute lymphocyte count predicts the overall survival benefit from eribulin therapy, including eribulin re-administration, in HER2-negative advanced breast cancer patients: a single-institutional experience
|
Watanabe, J.
|
|
|
181 |
1 |
p. 211-220
|
article
|
| 2 |
Behavior of metastatic breast cancer according to subtype
|
Van Mechelen, Margot
|
|
|
181 |
1 |
p. 115-125
|
article
|
| 3 |
Breast implant-associated anaplastic large cell lymphoma: emotional impact and guidelines for psychological support
|
Oliveri, Serena
|
|
|
181 |
1 |
p. 221-224
|
article
|
| 4 |
Comparison of outcomes in a population-based cohort of metastatic breast cancer patients receiving anti-HER2 therapy with clinical trial outcomes
|
Gong, Inna Y.
|
|
|
181 |
1 |
p. 155-165
|
article
|
| 5 |
Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors
|
Franzoi, Maria Alice
|
|
|
181 |
1 |
p. 199-209
|
article
|
| 6 |
Frequency of radiation-induced malignancies post-adjuvant radiotherapy for breast cancer in patients with Li-Fraumeni syndrome
|
Le, Anh N.
|
|
|
181 |
1 |
p. 181-188
|
article
|
| 7 |
HER2 borderline is a negative prognostic factor for primary malignant breast cancer
|
Bhattacharjee, Atanu
|
|
|
181 |
1 |
p. 225-231
|
article
|
| 8 |
Insulin-like growth factor-1 receptor (IGF-1R) expression on circulating tumor cells (CTCs) and metastatic breast cancer outcome: results from the TransMYME trial
|
Gennari, Alessandra
|
|
|
181 |
1 |
p. 61-68
|
article
|
| 9 |
LLY17, a novel small molecule STAT3 inhibitor induces apoptosis and suppresses cell migration and tumor growth in triple-negative breast cancer
|
Pan, Li
|
|
|
181 |
1 |
p. 31-41
|
article
|
| 10 |
Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer
|
Brandberg, Yvonne
|
|
|
181 |
1 |
p. 87-96
|
article
|
| 11 |
Meta-analyses on progression-free survival as a surrogate endpoint for overall survival in triple-negative breast cancer
|
Hirai, Takehiro
|
|
|
181 |
1 |
p. 189-198
|
article
|
| 12 |
Metformin is distributed to tumor tissue in breast cancer patients in vivo: A 11C-metformin PET/CT study
|
Sundelin, Elias Immanuel Ordell
|
|
|
181 |
1 |
p. 107-113
|
article
|
| 13 |
Mitotic score and pleomorphic histology in invasive lobular carcinoma of the breast: impact on disease-free survival
|
Mukhtar, Rita A.
|
|
|
181 |
1 |
p. 23-29
|
article
|
| 14 |
Neoadjuvant treatment strategies for HER2-positive breast cancer: cost-effectiveness and quality of life outcomes
|
Hassett, M. J.
|
|
|
181 |
1 |
p. 43-51
|
article
|
| 15 |
Obesity-associated methylation in breast tumors: a possible link to disparate outcomes?
|
Do, Whitney L.
|
|
|
181 |
1 |
p. 135-144
|
article
|
| 16 |
Peritumoral edema as a biomarker of the aggressiveness of breast cancer: results of a retrospective study on a 3 T scanner
|
Panzironi, Giovanna
|
|
|
181 |
1 |
p. 53-60
|
article
|
| 17 |
Preserving fertility in young women undergoing chemotherapy for early breast cancer; the Maastricht experience
|
Vriens, Ingeborg J. H.
|
|
|
181 |
1 |
p. 77-86
|
article
|
| 18 |
Racial differences in estrogen receptor staining levels and implications for treatment and survival among estrogen receptor positive, HER2-negative invasive breast cancers
|
Purrington, Kristen S.
|
|
|
181 |
1 |
p. 145-154
|
article
|
| 19 |
Risk-reducing mastectomy: a case series of 124 procedures in Brazilian patients
|
Frasson, Antônio Luiz
|
|
|
181 |
1 |
p. 69-75
|
article
|
| 20 |
Safety and tolerability of subcutaneous trastuzumab at home administration, results of the phase IIIb open-label BELIS study in HER2-positive early breast cancer
|
Denys, Hannelore
|
|
|
181 |
1 |
p. 97-105
|
article
|
| 21 |
The association between soy isoflavone intake and menopausal symptoms after breast cancer diagnosis: a prospective longitudinal cohort study on Chinese breast cancer patients
|
Lei, Yuan-Yuan
|
|
|
181 |
1 |
p. 167-180
|
article
|
| 22 |
The Mitotic Activity Index in combination with Her2neu: a strong prognosticator in breast cancer
|
Jobsen, Jan J.
|
|
|
181 |
1 |
p. 13-21
|
article
|
| 23 |
The solute carrier SLC7A8 is a marker of favourable prognosis in ER-positive low proliferative invasive breast cancer
|
El Ansari, Rokaya
|
|
|
181 |
1 |
p. 1-12
|
article
|
| 24 |
Ultrasound characteristics of sclerosing adenosis mimicking breast carcinoma
|
Liu, Wei
|
|
|
181 |
1 |
p. 127-134
|
article
|
Journal description